BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 16669966)

  • 1. Rethinking the peritoneal dialysis prescription: results of recent studies.
    Bargman JM
    Nephrology (Carlton); 2006 Apr; 11(2):85-9. PubMed ID: 16669966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What we have learned about uremia from peritoneal dialysis.
    Nolph KD
    ASAIO J; 1992; 38(4):745-50. PubMed ID: 1450467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining peritoneal dialysis adequacy: Kt/Vurea revisited.
    Zhe XW; Shan YS; Cheng L; Tian XK; Wang T
    Ren Fail; 2007; 29(3):347-52. PubMed ID: 17497450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-solute and middle-molecule clearances during continuous flow peritoneal dialysis.
    Leypoldt JK; Burkart JM
    Adv Perit Dial; 2002; 18():26-31. PubMed ID: 12402582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prescription of peritoneal dialysis.
    Tzamaloukas AH; Raj DS; Onime A; Servilla KS; Vanderjagt DJ; Murata GH
    Semin Dial; 2008; 21(3):250-7. PubMed ID: 18248525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urea kinetic and middle molecule approaches to assessing the adequacy of hemodialysis and CAPD.
    Keshaviah P
    Kidney Int Suppl; 1993 Feb; 40():S28-38. PubMed ID: 8445836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More of the same: improving outcomes through intensive hemodialysis.
    McFarlane PA
    Semin Dial; 2009; 22(6):598-602. PubMed ID: 20017828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dialysis adequacy indices for peritoneal dialysis and hemodialysis.
    Debowska M; Waniewski J; Lindholm B
    Adv Perit Dial; 2005; 21():94-7. PubMed ID: 16686294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of metabolic syndrome with residual renal function, solute transport rate and peritoneal solute clearance in chronic peritoneal dialysis patients.
    Chen HY; Kao TW; Huang JW; Chu TS; Wu KD
    Blood Purif; 2008; 26(2):138-44. PubMed ID: 18212496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sad but forgotten truth: the story of slow-moving solutes in fast hemodialysis.
    Eloot S; Van Biesen W; Vanholder R
    Semin Dial; 2012; 25(5):505-9. PubMed ID: 22925227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urea and uremic solutes: how does peritoneal dialysis work?
    Bammens B
    Semin Nephrol; 2011 Mar; 31(2):127-37. PubMed ID: 21439427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting the peritoneal dialysis dose.
    Moran J; Correa-Rotter R
    Semin Dial; 2006; 19(2):102-4. PubMed ID: 16551285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solutes transport characteristics in peritoneal dialysis: variations in glucose and insulin serum levels.
    da Silva DR; Figueiredo AE; Antonello IC; Poli de Figueiredo CE; d'Avila DO
    Ren Fail; 2008; 30(2):175-9. PubMed ID: 18300117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrectomy and peritoneal dialysis eliminates circulating renin and controls uraemia in the rat.
    Pedersen TF; Nielsen AH; Strandgaard S; Paulson OB
    J Renin Angiotensin Aldosterone Syst; 2002 Jun; 3(2):130-4. PubMed ID: 12228855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simplified approach to understanding urea kinetics in peritoneal dialysis.
    Misra M; Nolph K
    J Ren Nutr; 2007 Jul; 17(4):282-5. PubMed ID: 17586428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dialysis treatment of chronic kidney insufficiency in the uremic phase. Indications and limitations].
    Garini G; Savazzi G; Arisi L
    Recenti Prog Med; 1986 Sep; 77(9):440-3. PubMed ID: 3797795
    [No Abstract]   [Full Text] [Related]  

  • 17. Determinants of small solute clearance in hemodialysis.
    Huang Z; Clark WR; Gao D
    Semin Dial; 2005; 18(1):30-5. PubMed ID: 15663761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of the effectiveness and benefits of peritoneal dialysis and haemodialysis using Nigerian made PD fluids.
    Arogundade FA; Ishola DA; Sanusi AA; Akinsola A
    Afr J Med Med Sci; 2005 Sep; 34(3):227-33. PubMed ID: 16749353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convective therapies for removal of middle molecular weight uremic toxins in end-stage renal disease: a review of the evidence.
    Thomas G; Jaber BL
    Semin Dial; 2009; 22(6):610-4. PubMed ID: 20017830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New technologies in peritoneal dialysis.
    Bargman JM
    Clin J Am Soc Nephrol; 2007 May; 2(3):576-80. PubMed ID: 17699465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.